SCHEMBL2890615

SCHEMBL2890615

Brc1cccc([I+]c2cccc(Br)c2)c1.F[B-](F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 1/20 0.39
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
KMT2A Q03164 1/20 0.34
C1S P09871 1/20 0.33
PARP1 P09874 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30540400 0.94 ALDH1A1 (0.39) KDM1AALDH1A1MAPK1MEN1KMT2A
SCHEMBL3963493 0.91 ALDH1A1 (0.46) KDM1AALDH1A1MAPK1HTR2AHTR2C
SCHEMBL30540397 0.73 ALDH1A1 (0.48) KDM1AALDH1A1MAPK1HTR2AMEN1
SCHEMBL4949117 0.73 ACHE (0.48) ALDH1A1MAPK1HTR2AHTR2CHTR2B
SCHEMBL2898174 0.73 ALDH1A1 (0.39) ALDH1A1HTR2AHTR2CHTR2BMEN1
SCHEMBL29085620 0.71 MAOB (0.47) ALDH1A1MAPK1TAAR1
SCHEMBL28873734 0.70 MAOB (0.46) ALDH1A1MAPK1TAAR1
SCHEMBL10958964 0.69 ALDH1A1 (0.39) KDM1AALDH1A1MAPK1HTR2CHTR2B
SCHEMBL7680400 0.69 ALDH1A1 (0.39) KDM1AALDH1A1MAPK1HTR2CHTR2B
SCHEMBL5556827 0.69 ALDH1A1 (0.39) KDM1AALDH1A1MAPK1HTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678796-B2 MGluR5 modulators I ASTRAZENECA AB (SE) 2010-03-16 US disclosed
US-20070259926-A1 mGluR5 modulators III ASTRAZENECA AB (SE) 2007-11-08 US disclosed
US-20070259916-A1 mGluR5 modulators II ASTRAZENECA AB (SE) 2007-11-08 US disclosed
US-20070259862-A1 MGluR5 modulators I ASTRAZENECA AB (SE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070259862-A1 MGluR5 modulators I GRM5, GRM1, GRIK5 KDM1A 3180/4885ALDH1A1 4350/4885MAPK1 1996/4885
US-20070259926-A1 mGluR5 modulators III GRM5, GRM3, GRIK5 KDM1A 3533/4885ALDH1A1 4536/4885MAPK1 2236/4885
US-20070259916-A1 mGluR5 modulators II GRM5, GRM2, GRIK5 KDM1A 3618/4885ALDH1A1 4552/4885MAPK1 2361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.